HN1998000099A - Formas de dosificacion de sertralina de liberacion retardada - Google Patents

Formas de dosificacion de sertralina de liberacion retardada

Info

Publication number
HN1998000099A
HN1998000099A HN1998000099A HN1998000099A HN1998000099A HN 1998000099 A HN1998000099 A HN 1998000099A HN 1998000099 A HN1998000099 A HN 1998000099A HN 1998000099 A HN1998000099 A HN 1998000099A HN 1998000099 A HN1998000099 A HN 1998000099A
Authority
HN
Honduras
Prior art keywords
dosage forms
delayed release
release sertraline
sertraline
sertaline
Prior art date
Application number
HN1998000099A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN1998000099(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN1998000099A publication Critical patent/HN1998000099A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A FORMAS DE DOSIFICACION DE SERTALINA DE LIBERACION RETARDADA.
HN1998000099A 1997-07-01 1998-06-30 Formas de dosificacion de sertralina de liberacion retardada HN1998000099A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5149997P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
HN1998000099A true HN1998000099A (es) 1998-10-22

Family

ID=21971681

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1998000099A HN1998000099A (es) 1997-07-01 1998-06-30 Formas de dosificacion de sertralina de liberacion retardada

Country Status (41)

Country Link
EP (1) EP1007024B1 (es)
JP (1) JP3786715B2 (es)
KR (1) KR100369698B1 (es)
CN (4) CN1494899A (es)
AP (1) AP1199A (es)
AR (1) AR038394A2 (es)
AT (1) ATE245415T1 (es)
AU (1) AU727152B2 (es)
BG (1) BG64742B1 (es)
BR (1) BR9809895A (es)
CA (1) CA2290969C (es)
DE (1) DE69816624T2 (es)
DK (1) DK1007024T3 (es)
DZ (1) DZ2547A1 (es)
EA (1) EA001906B1 (es)
ES (1) ES2202858T3 (es)
GT (1) GT199800091A (es)
HK (1) HK1027982A1 (es)
HN (1) HN1998000099A (es)
HR (1) HRP980376B1 (es)
HU (1) HUP0301787A3 (es)
ID (1) ID23187A (es)
IL (2) IL152304A0 (es)
IS (1) IS5267A (es)
MA (1) MA24585A1 (es)
NO (1) NO996519L (es)
NZ (1) NZ501249A (es)
OA (1) OA11247A (es)
PA (1) PA8454201A1 (es)
PE (1) PE84399A1 (es)
PL (1) PL337799A1 (es)
PT (1) PT1007024E (es)
SI (1) SI1007024T1 (es)
SK (1) SK173299A3 (es)
TN (1) TNSN98122A1 (es)
TR (1) TR199903295T2 (es)
TW (1) TW575437B (es)
UA (1) UA63953C2 (es)
UY (1) UY25068A1 (es)
WO (1) WO1999001122A1 (es)
ZA (1) ZA985710B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1126826E (pt) 1998-11-02 2008-11-25 Elan Pharma Int Ltd Composição de metilfenidato de libertação modificada multiparticulada
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
CA2698347A1 (en) * 1999-05-20 2000-11-30 Elan Pharma International Limited Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
ATE318135T1 (de) 1999-09-03 2006-03-15 Apbi Holdings Llc Verwendung von dapoxetin, a selektiver serotonin- aufnahme inhibitor mit schnellem wirkungseintritt,zur behandlung von sexueller dysfunction
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
IL150850A0 (en) * 2000-02-10 2003-02-12 Bpsi Holdings Inc Enteric coating compositions containing acrylic resin
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
EP1377276B1 (en) * 2001-04-10 2011-10-05 Sun Pharma Advanced Research Company Limited Timed pulse release composition
WO2003013480A1 (en) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
EP2586429A1 (en) * 2011-10-26 2013-05-01 Freund Pharmatec Ltd. Multi-unit drug delivery device for pulsatile or sustained release
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) * 2021-11-19 2022-07-05 浙江维康药业股份有限公司 一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0357364B1 (en) * 1988-08-30 1993-07-28 E.I. Du Pont De Nemours And Company A process for flash-spinning dry polymeric plexifilamentary film-fibril strands
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings

Also Published As

Publication number Publication date
PT1007024E (pt) 2003-11-28
ATE245415T1 (de) 2003-08-15
MA24585A1 (fr) 1998-12-31
SI1007024T1 (en) 2003-12-31
CN1475209A (zh) 2004-02-18
PL337799A1 (en) 2000-09-11
CN1261273A (zh) 2000-07-26
NO996519L (no) 2000-02-29
CN1494899A (zh) 2004-05-12
HUP0301787A3 (en) 2005-04-28
SK173299A3 (en) 2000-11-07
KR100369698B1 (ko) 2003-01-30
DZ2547A1 (fr) 2003-02-08
AP9801278A0 (en) 1998-06-30
ID23187A (id) 2000-03-23
TW575437B (en) 2004-02-11
JP2000513751A (ja) 2000-10-17
IL133081A (en) 2005-09-25
EP1007024B1 (en) 2003-07-23
NZ501249A (en) 2001-06-29
CN1475208A (zh) 2004-02-18
AR038394A2 (es) 2005-01-12
KR20010013522A (ko) 2001-02-26
AU727152B2 (en) 2000-12-07
EA001906B1 (ru) 2001-10-22
UY25068A1 (es) 2000-12-29
HK1027982A1 (en) 2001-02-02
IS5267A (is) 1999-11-23
CN1151783C (zh) 2004-06-02
EP1007024A1 (en) 2000-06-14
NO996519D0 (no) 1999-12-28
ZA985710B (en) 2000-01-10
ES2202858T3 (es) 2004-04-01
PA8454201A1 (es) 2000-09-29
BR9809895A (pt) 2000-08-01
WO1999001122A1 (en) 1999-01-14
OA11247A (en) 2002-11-19
CA2290969C (en) 2004-02-17
JP3786715B2 (ja) 2006-06-14
AU7545198A (en) 1999-01-25
PE84399A1 (es) 1999-09-11
TNSN98122A1 (fr) 2005-03-15
CA2290969A1 (en) 1999-01-14
HUP0301787A2 (hu) 2003-11-28
AP1199A (en) 2003-08-28
HRP980376A2 (en) 1999-04-30
DE69816624T2 (de) 2004-02-19
BG64742B1 (bg) 2006-02-28
UA63953C2 (uk) 2004-02-16
TR199903295T2 (xx) 2000-08-21
HRP980376B1 (en) 2002-12-31
GT199800091A (es) 1999-12-21
IL152304A0 (en) 2003-05-29
DE69816624D1 (de) 2003-08-28
DK1007024T3 (da) 2003-11-17
IL133081A0 (en) 2001-03-19
BG103916A (en) 2000-07-31
EA199900965A1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
HN1998000115A (es) Formas de dosificación farmacéuticas sólidas
HN1998000099A (es) Formas de dosificacion de sertralina de liberacion retardada
HN1998000132A (es) Combinaciones terapeuticas
HN1999000066A (es) Formulaciones farmaceuticas
HN1997000097A (es) Piridinas condensadas con heterociclicos
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1998000124A (es) Terapia de combinacion
BR9806213A (pt) Forma de dosagem transdérmica.
HN1997000090A (es) Compuestos de piridilpirrol
HN1998000177A (es) Compuestos azopoliciclicos condensados con arilo
HN1996000101A (es) Terapia combinada para la osteoporosis
HN1998000174A (es) Combinacion eficaz para el tratamiento de la impotencia
HN1998003689A (es) Azetidinas
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998000088A (es) Tratamiento de resistencia a la insulina
HN1998000106A (es) Composiciones parenterales de alatroflaxacino
HN1998000028A (es) Otropisomeros de 3 heteroaril - 4 (3h) - quinazolinonas.
HN1998000045A (es) Composiciones farmaceuticas
HN1998000193A (es) Compuestos de triazina
HN1998000102A (es) Composiciones solubilizadas de sertralina
HN1998000096A (es) Formas de dosificación de solución encapsulada de sertralina
HN1999000202A (es) Derivados de higromicina
AR026913A1 (es) Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales
HN1998000103A (es) Sales de sertralina y formas de dosificacion de liberacion sostenida de sertralina
HN1998000024U (es) Anillo promocional